Literature DB >> 8132568

High affinity binding of the heat-stable protein kinase inhibitor to the catalytic subunit of cAMP-dependent protein kinase is selectively abolished by mutation of Arg133.

W Wen1, S S Taylor.   

Abstract

The two classes of physiological inhibitors of the catalytic subunit of cAMP-dependent protein kinase are the regulatory subunits and the heat-stable protein kinase inhibitors (PKIs), and both share a common mechanism of inhibition. Each has a similar inhibitor site that resembles a peptide substrate, and this occupies the P-3 to P+1 portion of the peptide recognition site. However, in addition to this consensus site, each inhibitor requires a peripheral binding site to achieve high affinity binding. Arg134 and Arg133 lie on the surface of the catalytic subunit with Arg133 coming close to the amphipathic helix of PKI(5-24) (Knighton, D. R., Zheng, J., Ten Eyck, L. F., Xuong, N.-h., Taylor, S. S., and Sowadski, J. M. (1991) Science 253, 414-420). Replacement of Arg134 and Arg133 with Ala selectively abolishes the high affinity binding of PKI. Replacement of Arg133 alone is sufficient to give the same phenotype. In the presence of MgATP, the Kd,app, is increased from < 0.2 to 105 nM and, in the absence of ATP, the Kd is too large to be reliably measured. Based on the crystal structure, Arg133 hydrogen bonds to the P-7 backbone carbonyl of PKI(5-24). However, more importantly, it also contributes to the hydrophobicity of the P-11 binding site in the C.PKI(5-24) complex. We predict that it is the perturbation of this hydrophobic pocket that accounts for the effects of this mutation. In the absence of peptide, Arg133 may help to stabilize Glu230, a buried carboxylate that binds to the P-2 Arg in the crystal structure of C.PKI(5-24). Replacement of Arg133 and Arg134 with Ala has little effect on catalysis using a heptapeptide substrate and has no effect on the inhibition of the catalytic subunit by the regulatory subunit. The results thus demonstrate that these two inhibitor proteins that both bind to the catalytic subunit with a high affinity utilize different sites on the enzyme to achieve tight binding. The gamma isoform of the catalytic subunit is insensitive to inhibition by PKI and in this isoform Arg133 is replaced with Gln. We predict that this change accounts for the altered inhibitor properties of C gamma.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8132568

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Inhibition of Xenopus oocyte meiotic maturation by catalytically inactive protein kinase A.

Authors:  Anja Schmitt; Angel R Nebreda
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

2.  Identification of electrostatic interaction sites between the regulatory and catalytic subunits of cyclic AMP-dependent protein kinase.

Authors:  R M Gibson; Y Ji-Buechler; S S Taylor
Journal:  Protein Sci       Date:  1997-09       Impact factor: 6.725

3.  Modulation of Drosophila slowpoke calcium-dependent potassium channel activity by bound protein kinase a catalytic subunit.

Authors:  Yi Zhou; Jing Wang; Hua Wen; Olga Kucherovsky; Irwin B Levitan
Journal:  J Neurosci       Date:  2002-05-15       Impact factor: 6.167

4.  Identification of the active region of the DNA synthesis inhibitory gene p21Sdi1/CIP1/WAF1.

Authors:  M Nakanishi; R S Robetorye; G R Adami; O M Pereira-Smith; J R Smith
Journal:  EMBO J       Date:  1995-02-01       Impact factor: 11.598

5.  Dopaminergic tone persistently regulates voltage-gated ion current densities through the D1R-PKA axis, RNA polymerase II transcription, RNAi, mTORC1, and translation.

Authors:  Wulf-Dieter C Krenz; Anna R Parker; Edmund W Rodgers; Deborah J Baro
Journal:  Front Cell Neurosci       Date:  2014-02-17       Impact factor: 5.505

6.  cAMP-dependent protein kinase (PKA) complexes probed by complementary differential scanning fluorimetry and ion mobility-mass spectrometry.

Authors:  Dominic P Byrne; Matthias Vonderach; Samantha Ferries; Philip J Brownridge; Claire E Eyers; Patrick A Eyers
Journal:  Biochem J       Date:  2016-07-21       Impact factor: 3.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.